Medical therapy for calculus disease.
Urolithiasis is a common problem with a high recurrence rate. Medical therapy directed to relieve agonizing pain, expulsion of stone, dissolution of uric acid and cystine stone and prevention of recurrence. NSAIDs are superior to opioids for renoureteral colic because their use doesn't induce vomiting and there is lesser requirement of rescue analgesia. In randomized trials, anticholinergics were not found to be beneficial. Alpha blockers, particularly tamsulosin, reduce pain and facilitate expulsion of stone and fragments of stone following extracorporeal shock wave lithotripsy (SWL) and ureterorenoscopic lithotripsy. Potassium citrate helps in chemodissolution of uric acid and cystine stones and is useful in prevention of stone recurrence in general and in those who have undergone SWL or percutaneious nephrolithotomy. Other measures for prevention of stone recurrence include fluid and dietary therapy, counteracting underlying metabolic abnormalities using suitable medications, phytotheurapeutic agents and probiotics. Once the role of nanobacteria is established in genesis of urinary stones, anti-nanobacteria therapy holds the promise of opening new horizons for prevention of urinary stones.
Postgraduate Institute of Medical Education and Research, Chandigarh, India. shrawanksingh2002@yahoo.com
Shrawan K
SK
Singh
Mayank Mohan
MM
Agarwal
Sumit
S
Sharma
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D003085:Colic / Q000188:drug therapy* / Q000209:etiology; D003131:Combined Modality Therapy; D005440:Fluid Therapy; D006801:Humans; D008096:Lithotripsy / Q000379:methods*; D019936:Probiotics / Q000627:therapeutic use; D055502:Secondary Prevention; D016896:Treatment Outcome; D052878:Urolithiasis / Q000628:therapy*
D000894:Anti-Inflammatory Agents, Non-Steroidal